SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Oracle and Broadcom rattle markets as AI trade hits a reality check

Hub Security to pay $11 million to settle claims over SPAC listing

Starlink selects Israeli chipmaker Xsight for V3 satellite network

Breaking electrolysis: Inside the Israeli startup betting on cheap green hydrogen

Buzz

Most popular

Daily

Weekly

1

ServiceNow in advanced talks to acquire Armis at around $7 billion valuation

2

Oracle’s stock has fallen 40% since Safra Catz announced her exit. Its latest earnings didn’t calm investors.

3

Freed Nvidia engineer Avinatan Or meets Jensen Huang at U.S. headquarters

4

After over $390 million in funding, Believer Meats abruptly shuts down

5

Shipping giant MSC submits bid for ZIM, challenging Hapag-Lloyd in takeover race

Entera

4 stories about Entera

Drug Developer Entera Bio Down on Nasdaq Following Amgen Deal

12.12.18|Lilach Baumer

The deal, announced Tuesday, could see Entera receive up to $270 million in aggregate payments

תרופות זירת הבריאות

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich

This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq

תל אביב קו רקיע Tel Aviv Skyline

CTech’s Daily Israeli Tech News Roundup

Israeli investment house to open crypto unit. A closer look at the first company funded by Koch’s new venture capital firm. Intuition Robotics expands funding round, nabbing Samsung as an investor.

נאסד"ק וול סטריט

For the Fourth Time, Entera Bio Tries for Nasdaq IPO

08.01.18|Dror Reich

The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter